Evaluation of acute phase proteins in hypertensive and obese patients;Ocena stȩżeń białek ostrej fazy u osób z nadciśnieniem tȩtniczym i otyłościa̧ prosta̧

Polski Merkuriusz Lekarski

Volumn 15, Issue 88, 2003, Pages 352-355

  Cymerys, Maciej ^a,c   Chyrek, Robert ^a   Bogdański, Paweł ^a   Ła̧cki, Jan ^b   Pupek Musialik, Danuta ^a   Januszewicz, Wlodzimierz ^a   Czekalski, Stanisław ^a   Manitius, Jacek ^a   Wańkowicz, Zofia ^a  

^a AM ^*

^b Poznan University of Medical Sciences Klinika Reumatologii i Immunologii Klinicznej   (Poland)

^c Katedra i Klinika Ftyzjopneumonologii   (Poland)

Author keywords

Acute phase proteins; Arterial hypertension; Interleukin 6

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CONCANAVALIN A; INTERLEUKIN 6; OROSOMUCOID; TRANSFERRIN;

ADULT; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EVALUATION; FEMALE; GLYCOSYLATION; HUMAN; HYPERTENSION; IMMUNOELECTROPHORESIS; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN ANALYSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SMOKING; ADOLESCENT; AGED; ARTICLE; METABOLISM; MIDDLE AGED;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY;

EID: 2342640316     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Ross R. Atherosclerosis - an inflammatory disease. New. Eng. J. Med., 1999, 340, 115-126.
2. Saadeddin S., Habbab M., Ferns G.: Markers of inflammation and coronary artery disease. Med. Sci. Monit., 2002, 8 (1), RA5-12.
3. Ridker P.M. i wsp.: C-reactive protein and other markers of inflammation of cardiovascu-lar disease in women. New. Eng. J. Med., 2000, 342, 836-43.
4. McCarty M.: Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity - down regulation with es-sential fatty acids, ethanol and pentoxyfilline. Med. Hypotheses, 1999, 52 (2), 465-77.
5. Yudkin J. i wsp.: C-reactive protein in healthy subjects: Association with obesity, insulin resistance and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol., 1999, 19, 972-8.
6. Madsen T. i wsp.: C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am. J. Cardiol., 2001, 88(10), 1139-42.
7. Chambers J. i wsp.: C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Asians from the United Kingdom compared with European whites. Circulation, 2001, 104, 145-150.
8. Folsom A. i wsp.: Association of C-reactive protein with markers of prevalent atheroscle-rotic disease. Am. J. Cardiol., 2001, 88, 112-117.
9. Bhakdi S.: Complement and atherogenesis: the unknown connection. Ann. Med., 1998, 30, 505-507.
10. Mackiewicz S., Hrycaj P.: Nowe aspekty odpowiedzi ostrej fazy. Post. Nauk Med., 1993, VI, 147-153.